Point72 Middle East FZE »

Avita Therapeutics shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $11k 803 13.71
2023-03-31 $64k 4.6k 13.97

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Avita Therapeutics

Vanguard Group
AWM Investment Company
Bank of New York Mellon
Dimensional Fund Advisors
Soleus Capital Management
1492 Capital Management
Charles Schwab Investment Management
AQR Capital Management
D. E. Shaw & Co
Hussman Econometrics Advisors
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Two Sigma Advisers
Bank of America Corporation
Barclays
Rhumbline Advisers

View all funds holding Avita Therapeutics